Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease
Citation
Mark, T., Mucha, L., Want, S. S., Cuffel, B., McRae, T., & Del Valle, M. (2008). Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer’s Disease. Journal of Managed Care Pharmacy, 22(1), 451-461. [PMID: 18597574]. DOI: 10.18553/jmcp.2008.14.5.451
Abstract
Sustained treatment with a cholinesterase inhibitor (ChEI) is used in the management of the symptoms of Alzheimer's disease (AD). However, the characteristic declines in learning and memory seen in AD may erode the patient's ability to adhere to medication regimens with or without caregiver support.